{"entity":{"type":"insider","cik":"0001446372","url":"/insider/0001446372","json_url":"/insider/0001446372.json","name":"Silva Paul M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":265,"n_filings":106,"first":"2008-11-19","last":"2021-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Silva Paul M","source":"filing","n_filings":106,"first_seen":"2008-11-19","last_seen":"2021-03-02"}],"transactions":[{"id":4883533,"accession":"0001209191-21-015849","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-015849","line_url":"/filing/0001209191-21-015849","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2782.0,"shares_display":"2,782","price_per_share":211.45048526240114,"price_display":"211.45","price_state":"stated","total_value":588255.25,"total_display":"588,255.25","total_whole":"588,255","shares_owned_after":11640.0,"shares_owned_after_display":"11,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider","n_lines":4},{"id":5374374,"accession":"0001209191-21-014749","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-014749","line_url":"/filing/0001209191-21-014749","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1080.0,"shares_display":"1,080","price_per_share":213.4736111111111,"price_display":"213.47","price_state":"stated","total_value":230551.5,"total_display":"230,551.50","total_whole":"230,552","shares_owned_after":15268.0,"shares_owned_after_display":"15,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-26","scope":"insider","n_lines":4},{"id":4138096,"accession":"0001209191-21-012355","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-012355","line_url":"/filing/0001209191-21-012355","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4295.0,"shares_display":"4,295","price_per_share":211.83413736903375,"price_display":"211.83","price_state":"stated","total_value":909827.62,"total_display":"909,827.62","total_whole":"909,828","shares_owned_after":18196.0,"shares_owned_after_display":"18,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-19","scope":"insider","n_lines":3},{"id":5321538,"accession":"0001209191-21-010739","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-010739","line_url":"/filing/0001209191-21-010739","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1498.0,"shares_display":"1,498","price_per_share":210.57196261682242,"price_display":"210.57","price_state":"stated","total_value":315436.8,"total_display":"315,436.80","total_whole":"315,437","shares_owned_after":24073.0,"shares_owned_after_display":"24,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider","n_lines":2},{"id":2041849,"accession":"0001209191-20-045942","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-045942","line_url":"/filing/0001209191-20-045942","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1078.0,"shares_display":"1,078","price_per_share":271.16776437847864,"price_display":"271.17","price_state":"stated","total_value":292318.85,"total_display":"292,318.85","total_whole":"292,319","shares_owned_after":15590.0,"shares_owned_after_display":"15,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-06","filed_date":"2020-08-10","scope":"insider","n_lines":4},{"id":2077123,"accession":"0001209191-20-045105","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-045105","line_url":"/filing/0001209191-20-045105","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":809.0,"shares_display":"809","price_per_share":278.29613102595795,"price_display":"278.30","price_state":"stated","total_value":225141.57,"total_display":"225,141.57","total_whole":"225,142","shares_owned_after":14951.0,"shares_owned_after_display":"14,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":4},{"id":3042298,"accession":"0001209191-20-042492","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-042492","line_url":"/filing/0001209191-20-042492","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":860.0,"shares_display":"860","price_per_share":292.02860465116277,"price_display":"292.03","price_state":"stated","total_value":251144.6,"total_display":"251,144.60","total_whole":"251,145","shares_owned_after":15032.0,"shares_owned_after_display":"15,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-15","scope":"insider","n_lines":7},{"id":2469696,"accession":"0001209191-20-030487","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-030487","line_url":"/filing/0001209191-20-030487","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":151.0,"shares_display":"151","price_per_share":284.0038410596026,"price_display":"284.00","price_state":"stated","total_value":42884.58,"total_display":"42,884.58","total_whole":"42,885","shares_owned_after":14932.0,"shares_owned_after_display":"14,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider","n_lines":7},{"id":2286214,"accession":"0001209191-20-027904","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-027904","line_url":"/filing/0001209191-20-027904","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076.0,"shares_display":"1,076","price_per_share":272.74328996282526,"price_display":"272.74","price_state":"stated","total_value":293471.78,"total_display":"293,471.78","total_whole":"293,472","shares_owned_after":15452.0,"shares_owned_after_display":"15,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-08","scope":"insider","n_lines":6},{"id":2435895,"accession":"0001209191-20-027476","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-027476","line_url":"/filing/0001209191-20-027476","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":809.0,"shares_display":"809","price_per_share":260.8748454882571,"price_display":"260.87","price_state":"stated","total_value":211047.75,"total_display":"211,047.75","total_whole":"211,048","shares_owned_after":15291.0,"shares_owned_after_display":"15,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-04","filed_date":"2020-05-06","scope":"insider","n_lines":5},{"id":2179054,"accession":"0001209191-20-024476","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-024476","line_url":"/filing/0001209191-20-024476#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193.0,"shares_display":"193","price_per_share":250.29,"price_display":"250.29","price_state":"stated","total_value":48305.97,"total_display":"48,305.97","total_whole":"48,306","shares_owned_after":15098.0,"shares_owned_after_display":"15,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"},{"id":2179050,"accession":"0001209191-20-024476","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-024476","line_url":"/filing/0001209191-20-024476#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":252.26,"price_display":"252.26","price_state":"stated","total_value":41875.16,"total_display":"41,875.16","total_whole":"41,875","shares_owned_after":14932.0,"shares_owned_after_display":"14,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"},{"id":2179046,"accession":"0001209191-20-024476","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-024476","line_url":"/filing/0001209191-20-024476#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":248.96,"price_display":"248.96","price_state":"stated","total_value":37344.0,"total_display":"37,344.00","total_whole":"37,344","shares_owned_after":15291.0,"shares_owned_after_display":"15,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"},{"id":2179040,"accession":"0001209191-20-024476","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-024476","line_url":"/filing/0001209191-20-024476#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001446372","owner_name":"Silva Paul M","owner_display_name":"Silva Paul M","owner_url":"/insider/0001446372","role":"Officer (SVP & Controller)","role_mark":"O","role_mark_label":"Officer (SVP & Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":247.18,"price_display":"247.18","price_state":"stated","total_value":37077.0,"total_display":"37,077.00","total_whole":"37,077","shares_owned_after":15441.0,"shares_owned_after_display":"15,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"}],"collapsed":true,"next_cursor":"2020-04-13|2179040","ledger_fault":false,"count":{"value":265,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":265,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":265},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (SVP & Chief Accounting Officer)","n_filings":106,"first_seen":"2008-11-19","last_seen":"2021-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001446372","retrieved_at":"2026-08-22T22:53:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}